Late follicular progesterone to estradiol ratio is not influenced by protocols or gonadotropins used

Reprod Biol Endocrinol. 2015 Nov 5:13:119. doi: 10.1186/s12958-015-0116-y.

Abstract

Objective: Increased progesterone level during follicular phase seemed to be associated with decreased pregnancy rate.

Study design and methods: A prospective cohort study, 1.1.2012 - 31.8.13. The Progesterone (P) and Progesterone/Estrogen (P/E2) level on ovulation induction day were compared between the protocols and the different gonadotropins used. Roc analysis was calculated to determine the cutoff of P/E2 to predict delivery rates. P/E2 ratio was calculated as PX1000/e2 level.

Main results: One hundred thirty-nine patients were enrolled to the study. No difference in the P level at hCG stimulation day between different protocols, however, E2 and P/E2 ratio were significantly lower in the long protocol compare with antagonist protocol 1757.7 ± 923.2 vs. 1342.9 ± 1223; P = 0.003 and 0.48 ± 0.31 vs. 0.83 ± 0.87; P = 0.038). The endometrium was significantly thicker in the long group compare with short and antagonist. Significantly more top-quality embryos (TOP) were achieved in the antagonist group. Comparable results between the types of gonadotropins used in regards with cycle characteristics and pregnancy and delivery rates. The P/E2 ratio which can predict live birth rate was found to be 0.45, AUC = 0.632, p = 0.02 and 95 % CI 0.525-0.738 and a significantly higher pregnancy and delivery rates at a P/E2 bellow 0.45.

Conclusion: Endometrial receptivity is determined by the complex interactions of E2 and P.

MeSH terms

  • Adult
  • Drug Therapy, Combination
  • Endometrium / drug effects
  • Estradiol / blood*
  • Female
  • Follicle Stimulating Hormone / pharmacology
  • Follicle Stimulating Hormone / therapeutic use*
  • Follicular Phase / blood*
  • Follicular Phase / drug effects*
  • Humans
  • Menotropins / pharmacology
  • Menotropins / therapeutic use*
  • Ovulation Induction / methods*
  • Pregnancy
  • Pregnancy Rate
  • Progesterone / blood*
  • Prospective Studies
  • Treatment Outcome

Substances

  • Progesterone
  • Estradiol
  • Menotropins
  • Follicle Stimulating Hormone